Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hippo Holdings Inc. filings document formal disclosures for a NYSE-listed insurance technology company with common stock trading under HIPO. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentations, supplemental financial information, and reconciliations of non-GAAP measures to GAAP measures.
The company’s proxy filings cover annual meeting materials, stockholder voting matters, board governance, and public-company disclosure requirements. Together, the filing record emphasizes Hippo’s insurance-platform performance, premium and underwriting metrics, capital and equity disclosures, and governance framework.
Hippo Holdings Inc. received a notice that an individual security holder plans to sell 5,000 shares of its common stock under Rule 144. The shares were originally acquired as 5,000 restricted stock units from Hippo Holdings Inc. on 12/24/2020. The planned sale is to be executed through Merrill Lynch on the NYSE around 01/09/2026, with an indicated aggregate market value of $157,600 and with 25,335,179 common shares outstanding. The form also reports that the same seller disposed of 5,000 common shares on 12/09/2025 for gross proceeds of $149,100 during the prior three months.
Hippo Holdings Inc. officer GM & Chief Insurance, HHIP, Michael Stienstra reported a sale of company stock. On December 22, 2025, he sold 3,900 shares of common stock at a weighted average price of $31.1194 per share, executed in multiple trades between $31.01 and $31.25. The sales were made under a pre-arranged Rule 10b5-1 trading plan dated September 21, 2025, which is designed to provide an affirmative defense for insider trading when properly used. After this transaction, Stienstra beneficially owned 71,281 shares, including 37,874 restricted stock units (RSUs), all reported as directly held.
An insider of the company with ticker HIPO has filed a notice to sell 3,900 shares of its common stock through broker Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $120,471.00, compared with 25,335,179 shares outstanding of the same class. The securities to be sold were acquired from the issuer as restricted stock units and performance stock units on 08/15/2025 and 09/10/2025, in amounts of 2,627 and 1,273 shares respectively, with payment noted as non-cash. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Hippo Holdings Inc. director reports charitable stock gift
A director of Hippo Holdings Inc. reported donating 4,935 shares of common stock on 12/18/2025 in a transaction coded as a gift at a price of $0.00 per share. After this donation, the director beneficially owns 16,563 shares of common stock directly, including 4,738 restricted stock units, and 50,000 shares indirectly through Janajasa Associates L.P. The filing reflects a personal charitable transfer rather than an open-market sale.
Hippo Holdings Inc. insider activity: Chief Executive Officer and director Richard McCathron reported selling 5,000 shares of Hippo common stock on 12/09/2025 at a price of $29.82 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan dated August 29, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following this transaction, McCathron beneficially owns 452,704 shares of Hippo common stock, which includes 181,675 restricted stock units (RSUs).
Hippo Holdings Inc. has a planned sale of restricted stock reported under Rule 144. The notice covers up to 5,000 shares of common stock to be sold through Merrill Lynch on the NYSE, with an aggregate market value of $149,100. These shares were acquired as restricted stock units from Hippo Holdings Inc. on 05/15/2023, in the same amount of 5,000 shares.
The filing states that 25,335,179 shares of the issuer’s common stock were outstanding, providing context on the size of the planned sale relative to the overall share base. The approximate sale date listed is 12/09/2025.
Hippo Holdings Inc. (HIPO) reported an insider stock sale by its officer serving as CEO of Spinnaker on a Form 4. On 11/21/2025, the reporting person sold 3,493 shares of common stock at a weighted average price of $31.9587, followed by a sale of 152 shares at a weighted average price of $32.6326. Both transactions were coded as open-market sales and were made under a Rule 10b5-1 trading plan dated August 22, 2025, which is designed to pre-schedule trades. After these transactions, the reporting person beneficially owned 55,207 shares of common stock, which includes 47,549 restricted stock units (RSUs), all reported as directly owned.
Hippo Holdings (HIPO) has a Form 144 notice covering a planned sale of 3,645 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of 115,109.10 and are part of a larger base of 25,335,000 shares outstanding. The proposed sale date is 11/21/2025. The seller acquired 1,553 shares via restricted stock units on 05/15/2025 and 2,092 shares via performance stock units on 09/09/2025, both from the issuer. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Hippo’s current or prospective operations.
Hippo Holdings Inc. (HIPO) Chief Financial Officer Guy Zeltser reported equity transactions in company stock. On 11/15/2025, 4,182 shares of common stock were disposed of in a transaction coded "F," typically used for tax withholding related to equity awards, at a reported price of $31.1137 per share. On 11/18/2025, he sold 1,719 shares at a weighted average price of $32.1231 and an additional 100 shares at $32.74, in sales noted as made under a Rule 10b5-1 trading plan dated June 18, 2025. Following these transactions, Zeltser beneficially owns 68,860 shares of Hippo common stock, which includes 57,997 restricted stock units (RSUs).
Hippo Holdings Inc. (HIPO) reported an insider equity transaction by its GM & Chief Insurance, HHIP, Michael Stienstra. On 11/15/2025, a disposition coded "F" of 2,463 shares of common stock at $31.1137 per share was reported. After this transaction, Stienstra beneficially owned 75,181 shares, which includes 37,874 restricted stock units (RSUs). The filing reflects routine reporting of changes in an executive’s equity holdings.